Spots Global Cancer Trial Database for colorectal cancer
Every month we try and update this database with for colorectal cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
A Study of the Safety and Biological Activity of Intraperitoneal (IP) EGEN-001 Administered Alone and in Combination With Standard Chemotherapy in Colorectal Peritoneal Carcinomatosis Patients | NCT01300858 | Colorectal Canc... | EGEN-001-301 | 18 Years - 80 Years | EGEN, Inc. | |
A Study of Xeloda (Capecitabine) in Patients With Advanced and/or Metastatic Colorectal Cancer | NCT00048126 | Colorectal Canc... | Irinotecan capecitabine [X... | 18 Years - | Hoffmann-La Roche | |
Assessment of Autologous Blood Marker Localization in Laparoscopic Colorectal Cancer Surgery | NCT05597384 | Colorectal Canc... | Laparoscopic co... | 18 Years - 80 Years | Shanghai East Hospital | |
Paclitaxel and Bortezomib in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors | NCT00667641 | Breast Cancer Colorectal Canc... Head and Neck C... Lung Cancer Melanoma (Skin) Ovarian Cancer Pancreatic Canc... Prostate Cancer Unspecified Adu... | bortezomib paclitaxel | 18 Years - | Rutgers, The State University of New Jersey | |
Microbiota-anastomotic Leak Among Colorectal Surgery Patients : Pilot Study | NCT03496441 | Colorectal Canc... Inflammatory Bo... Microbiota Anastomotic Lea... | Fecal sample co... | 18 Years - 90 Years | Centre hospitalier de l'Université de Montréal (CHUM) | |
BrUOG 379 Phase Ib/II Trial ONC201 + Nivolumab in MSS mCRC | NCT03791398 | Metastatic Colo... | Dose level 1 ON... Dose level 2 ON... Dose level 3 ON... | 18 Years - | Brown University | |
Possible Association of Intestinal Helminths and Protozoa With Colorectal Cancer Pathogenesis | NCT03173001 | Colorectal Canc... Colorectal Canc... Intestinal Para... Protozoan Infec... | Parasitological... | 18 Years - 90 Years | Research Institute of Epidemiology, Microbiology and Infectious Diseases, Uzbekistan | |
"The Impact of Immunonutrition on Gut Microbiota-related Aspects in Colorectal Cancer and Gastric Cancer Patients" | NCT04980950 | Gastric Cancer Colorectal Canc... | Impact Oral Nes... | 18 Years - 80 Years | Medical University of Gdansk | |
Indicators of Anastomotic Leak After Colorectal Surgery | NCT06156358 | Colorectal Canc... | No intervention | 12 Years - | King Abdulaziz University | |
Pilot Study of a Geriatric Intervention After Colorectal and Lung Cancer Surgery | NCT01416168 | Colorectal Canc... | McCorkle Model ... | 60 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
Capsule Versus Conventional Colonoscopy in Patient Following Colorectal Surgery | NCT01879943 | Colorectal Canc... | PillCam Colon 2 Colonoscopy | 18 Years - 85 Years | IHU Strasbourg | |
CRC Screening for High Risk Population in HK | NCT03597204 | Colorectal Canc... | Fecal immunoche... | 40 Years - 75 Years | Chinese University of Hong Kong | |
An Observational Study of Bevacizumab in Combination With 5-FU-Based Chemotherapy in Chinese Participants With Metastatic Colorectal Cancer | NCT01319877 | Colorectal Canc... | 18 Years - | Hoffmann-La Roche | ||
Xeloda Vs Monitoring in Advanced Colorectal Cancer Responsive to Chemotherapy | NCT00189683 | Colorectal Canc... | Monitoring Xeloda | 18 Years - | Association Européenne de Recherche en Oncologie | |
Child-Physician Recommendation on Parental Adherence to Colorectal Cancer Screening | NCT03304860 | Colorectal Canc... | Survey | 18 Years - | NYU Langone Health | |
Effects of Preoperative Correction of Anemia With Intravenously Iron in Colorectal Cancer Patients. | NCT05221957 | Colorectal Canc... Anemia Iron-deficiency | Iron(III)isomal... | 18 Years - | Zealand University Hospital | |
Promoting Colorectal Cancer Screening in Rural Colorado | NCT00137592 | Colorectal Canc... | small media, gr... | 50 Years - | Centers for Disease Control and Prevention | |
The Impact of Choice on Colorectal Cancer Screening | NCT05275530 | Colorectal Canc... Colorectal Neop... Health Screenin... | Active FIT Choi... Active Colonosc... Active Dual Cho... | 45 Years - 49 Years | University of California, Los Angeles | |
Fast Track Laparoscopic Surgery: A Better Option for Treating Colorectal Cancer Than Conventional Laparoscopic Surgery | NCT01969591 | Colorectal Canc... | fast-track surg... conventional po... | - 75 Years | The First Hospital of Jilin University | |
Comparing the Effectiveness of Written Vs Verbal Advice for First Degree Relatives of Colorectal Cancer Patients | NCT06242197 | Colorectal Canc... | written advice | 40 Years - 75 Years | Ramathibodi Hospital | |
Colonoscopic Skill Acquisition and Transfer Via Simulated Curriculum of Progressive Training | NCT02000180 | Colorectal Canc... | Progressive Gro... | - | Unity Health Toronto | |
Collection of Information to Better Understand Young Onset Colorectal Cancer | NCT04489238 | Colorectal Canc... Colorectal Carc... | Risk Factor Que... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
Social Media for Colorectal Cancer Screening | NCT04296630 | Colorectal Canc... Cancer Screenin... | Social media me... Social media me... Social media me... Tailored social... | 50 Years - | Unity Health Toronto | |
Financial Incentives to Increase Colorectal Cancer Screening in Priority Populations | NCT03080701 | Colorectal Canc... | Auto Mailing Pl... Auto Mailing Pl... | 50 Years - 75 Years | Kaiser Permanente | |
Bioequivalence Study of Trifluridine and Tipiracil Tablets in Colorectal Cancer Patients | NCT03974594 | Colorectal Canc... | Trifluridine an... TAS-102 | 18 Years - 70 Years | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | |
Magnification Narrow Band Imaging Colonoscopy for Hereditary Non-Polyposis Colorectal Cancer Surveillance | NCT00313755 | Colorectal Neop... | Narrow Band Ima... | 18 Years - | London North West Healthcare NHS Trust | |
A Phase 1 Study of OCV-C02 in Patients With Advanced or Relapsed Colorectal Cancer | NCT01801930 | Colorectal Canc... | OCV-103 and OCV... OCV-103 and OCV... OCV-103 and OCV... OCV-103 and OCV... | 20 Years - | Otsuka Pharmaceutical Co., Ltd. | |
Hepatic Arterial Infusion With Floxuridine and Dexamethasone Combined With Combination Chemotherapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver | NCT00492999 | Colorectal Canc... Metastatic Canc... | dexamethasone floxuridine fluorouracil irinotecan hydr... leucovorin calc... oxaliplatin | 18 Years - 120 Years | Memorial Sloan Kettering Cancer Center | |
The Impact of Remote Training on Colonoscopy KPIs | NCT06101836 | Training Colonoscopy Colorectal Canc... | Training interv... | 18 Years - | University Hospital, Ghent | |
Study to Increase Colorectal Screening | NCT02870049 | Colorectal Canc... | Inreach strateg... Outreach strate... Both Inreach an... Usual care | 50 Years - 75 Years | University of California, San Diego | |
Simultaneaous Detection of Quantitative Somatic Alterations Using the Qantitative Multiplex Pcr of Short Fluorescent Fragments Method (QMPSF) in Stage II-III Colon Cancer: a Prospective Study | NCT02110329 | Colorectal Canc... Stage II and II... | evaluation of t... | 18 Years - | University Hospital, Rouen | |
Targeted Next-generation Sequencing Panel for Identification of Germline Mutations in Early Onset Cancers With Sporadic or Hereditary Presentation | NCT02664389 | Breast Cancer Ovarian Cancer Colorectal Canc... Pediatric Cance... Multiple Primar... | Genetic analysi... | - | University Hospital, Rouen | |
Fluorouracil and Leucovorin With or Without Oxaliplatin in Treating Patients With Recurrent Metastatic Colorectal Cancer | NCT00016198 | Colorectal Canc... | FOLFOX regimen fluorouracil leucovorin calc... oxaliplatin | 18 Years - | National Cancer Institute (NCI) | |
Efficacy and Safety of Oxaliplatin Combined With Capecitabine as Neoadjuvant Chemotherapy for Locally Advanced Colon Cancer Patients | NCT02415829 | Colorectal Canc... | capecitabine pl... | 18 Years - 75 Years | Fudan University | |
A Study of SAR444245 Combined With Other Anticancer Therapies for the Treatment of Participants With Gastrointestinal Cancer (Master Protocol) (Pegathor Gastrointestinal 203) | NCT05104567 | Oesophageal Squ... Gastric Cancer Hepatocellular ... Colorectal Canc... Oesophageal Ade... | THOR-707 Pembrolizumab Cetuximab | 18 Years - | Sanofi | |
Colorectal Cancer (CRC) Surveillance Tool: Cognitive and Pilot Testing | NCT03180411 | Colorectal Canc... | Interview Questionnaire | 18 Years - | M.D. Anderson Cancer Center | |
T Helper Cytokines in End Stage Colorectal Cancers | NCT04540146 | Colorectal Canc... | Flow-Cytometric... | 18 Years - 80 Years | Istanbul Training and Research Hospital | |
Cold Snare Polypectomy Versus Endoscopic Mucosal Resection for Colonic Sessile Serrated Polyps | NCT02967107 | Colorectal Canc... Adenoma | Cold snare poly... Endoscopic muco... | 18 Years - | Western Sydney Local Health District | |
Interleukin-12 in Treating Patients With Cancer in the Abdomen | NCT00003046 | Anal Cancer Colorectal Canc... Gallbladder Can... Gastric Cancer Pancreatic Canc... | Recombinant Int... | 18 Years - | M.D. Anderson Cancer Center | |
Hand-Foot Exercises on Chemotheraphy Induced Peripheral Neuropathy Pain, Falls and Quality of Life in Colorectal Cancer | NCT05873829 | Chemotherapy-in... Colorectal Canc... | Hand-foot exerc... | 18 Years - | Gulhane Training and Research Hospital | |
Micrometastases and Angiogenesis in Colon Cancer. Prognostic Value of VEGF. | NCT04145505 | Colorectal Canc... Angiogenesis | COLORECTAL CANC... | 18 Years - | Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | |
Reolysin in Combination With FOLFOX6 and Bevacizumab or FOLFOX6 and Bevacizumab Alone in Metastatic Colorectal Cancer | NCT01622543 | Colorectal Canc... | Folfox plus Bev... Folfox plus Bev... | 18 Years - | Canadian Cancer Trials Group | |
Simo Decoction and Acupuncture on POI in Colorectal Cancer | NCT02813278 | Colorectal Canc... | simo decoction gum chewing | 18 Years - 75 Years | Guangxi Medical University | |
Influence of a Brief Intervention on CRC Screening | NCT02012829 | Colorectal Canc... | GPs communicati... | - | University Paris 7 - Denis Diderot | |
A Study of SGN-BB228 in Advanced Melanoma and Other Solid Tumors | NCT05571839 | Cutaneous Melan... Non-small Cell ... Colorectal Neop... Pancreatic Neop... Mesothelioma | SGN-BB228 | 18 Years - | Seagen Inc. | |
Faith-based Approaches to Treating Hypertension and Colon Cancer Prevention | NCT01405638 | Blood Pressure Colorectal Canc... | Motivational In... Patient Navigat... | 50 Years - | NYU Langone Health | |
A Prospective Study Utilizing Circulating Cell Free DNA (cfDNA) Use in the Detection of RAS Mutations in Patients With Advanced Colorectal Cancer. | NCT04775862 | Colon Cancer | investigator ch... | 18 Years - | National Guard Health Affairs | |
Capecitabine and Thalidomide in Previously Treated Metastatic Colorectal Carcinoma | NCT00165217 | Colorectal Aden... | Capecitabine Thalidomide | 18 Years - | Dana-Farber Cancer Institute | |
Incidence Rate of Perioperiative VTE in Colorectal Cancer Patients : a Multicenter Prospective Observational Cohort Study | NCT04588805 | Incidence Rate ... | - | Beijing Friendship Hospital | ||
Survivor Choices for Eating and Drinking - Colorectal Cancer | NCT02965521 | Colon Cancer Rectal Cancer ColoRectal Canc... | Website and tex... | 18 Years - | University of California, San Francisco | |
Assessment of Clinically Related Outcomes and Biomarker Analysis for Translational Integration in Colorectal Cancer | NCT01762813 | Colorectal Canc... | open and laparo... | 18 Years - | Helse Stavanger HF | |
Efficacy and Safety of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) in Previously Treated Participants With Select Solid Tumors (MK-7902-005/E7080-G000-224/LEAP-005) | NCT03797326 | Advanced Solid ... Triple Negative... Ovarian Cancer Gastric Cancer Colorectal Canc... Glioblastoma Biliary Tract C... Pancreatic Canc... | Pembrolizumab Lenvatinib | 18 Years - | Merck Sharp & Dohme LLC | |
Biological-guided Metronomic Chemotherapy as Maintenance Strategy in Metastatic Colorectal Cancer | NCT03158610 | Colorectal Canc... | Capecitabine | 18 Years - 75 Years | Ruijin Hospital | |
Clinical Performance of the Mainz Biomed Colorectal Cancer Screening Test for Colorectal Cancer and Advanced Adenoma | NCT05636085 | Colorectal Canc... Colorectal Neop... Colorectal Poly... Colorectal Aden... | Mainz Biomed Co... | 45 Years - | Mainz Biomed | |
Safety Study of 90Y-hMN14 to Treat Colorectal Cancer | NCT00040599 | Colorectal Canc... Colon Cancer Rectal Cancer Colorectal Neop... Colorectal Carc... Colorectal Tumo... | hMN14 (labetuzu... | 18 Years - | Gilead Sciences | |
Endoscopic Versus Surgical Treatment for T1 Colorectal Cancer | NCT04150081 | Colorectal Canc... | Surgery or Endo... | - | Hospital Clinic of Barcelona | |
Combination Chemotherapy and Cetuximab as First-Line Therapy in Treating Patients With Advanced and/or Metastatic Colorectal Cancer | NCT00640081 | Colorectal Canc... | cetuximab capecitabine fluorouracil leucovorin calc... oxaliplatin immunohistochem... laboratory biom... | 18 Years - 100 Years | Medical Research Council | |
Combination Chemotherapy and Intensity-Modulated Radiation Therapy in Treating Patients Undergoing Surgery for Locally Advanced Rectal Cancer | NCT00613080 | Colorectal Canc... | capecitabine oxaliplatin resection radiation thera... FOLFOX | 18 Years - | Radiation Therapy Oncology Group | |
Palonosetron Hydrochloride in Preventing Nausea and Vomiting Caused by Radiation Therapy in Patients With Primary Abdominal Cancer | NCT00903396 | Anal Cancer Carcinoma of th... Colorectal Canc... Extrahepatic Bi... Gallbladder Can... Gastric Cancer Gastrointestina... Liver Cancer Nausea and Vomi... Pancreatic Canc... Primary Periton... Small Intestine... | palonosetron hy... placebo | 18 Years - | Alliance for Clinical Trials in Oncology | |
Evaluation of the Incidence of Nausea and Vomiting in Patients With Colorectal Cancer Receiving Irinotecan-based Therapy | NCT00713128 | Colorectal Canc... | 18 Years - | Steward St. Elizabeth's Medical Center of Boston, Inc. | ||
Impact Study of a Digital Solution for Patient Engagement | NCT04153721 | Colorectal Canc... | Name Digital So... | 18 Years - | IHU Strasbourg | |
Study of NGM120 in Subjects With Advanced Solid Tumors, Pancreatic Cancer, and Prostate Cancer Using Combination Therapy | NCT04068896 | Pancreatic Canc... Metastatic Cast... Bladder Cancer Melanoma Non-small Cell ... Colorectal Canc... Gastric Cancer Esophageal Canc... Ovarian Cancer Head Neck Squam... Prostate Cancer | NGM120 NGM120 NGM120 NGM120 NGM120 NGM120 Placebo | 18 Years - | NGM Biopharmaceuticals, Inc | |
Colonoscopy Followup After Positive Fecal Occult Blood Test- Understanding Barriers to Adherence | NCT02534142 | Colorectal Canc... | 51 Years - 74 Years | Meuhedet. Healthcare Organization | ||
Single Incision Plus One Port Laparoscopic Surgery Assistant Enhanced Recovery After Surgery on Colorectal Cancer | NCT04268290 | Colorectal Canc... | Single incision... | 18 Years - 75 Years | Nanfang Hospital, Southern Medical University | |
Colon Investigation - Factors Determining Choice of Procedure | NCT00423345 | Irritable Colon Colorectal Canc... Inflammatory Bo... | 18 Years - | Sykehuset Telemark | ||
Clinical Study on the Efficacy of Autologous Cell Factor Induced Killer Cells in the Treatment of Colorectal Cancer | NCT05676190 | Colorectal Canc... | CIK combined wi... CIK combined im... CIK combined ta... CIK in combinat... | 18 Years - 70 Years | Southwest Hospital, China | |
Vitamin D Intervention and Associated Changes in the Gut Microbiome and Vitamin D Levels in Healthy Adults | NCT05387876 | Colorectal Canc... | Vitamin D inter... Placebo interve... | 18 Years - 79 Years | Baylor University | |
Erlotinib and Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer | NCT00049101 | Colorectal Canc... | erlotinib hydro... fluorouracil leucovorin calc... oxaliplatin | 18 Years - | National Cancer Institute (NCI) | |
The Feasibility of an Active Lifestyle Programme in Patients Recovering From Colorectal Cancer | NCT02751892 | Colorectal Canc... | Active lifestyl... | - | University of East Anglia | |
COLLISION Trial - Colorectal Liver Metastases: Surgery vs Thermal Ablation | NCT03088150 | ColoRectal Canc... Liver Metastasi... Liver Metastase... Surgery | Thermal ablatio... Surgical resect... | 18 Years - | Amsterdam UMC, location VUmc | |
Clinical Validation of ColonAiQ (a Blood-based Assay Targeting ctDNA Methylation) for Colorectal Cancer Detection | NCT06347887 | Colorectal Canc... | ColonAiQ test a... | 18 Years - | Singlera Genomics Inc. | |
Phase II Study of Simvastatin Plus Irinotecan, Fluorouracil, and Leucovorin(FOLFIRI) for Metastatic CRC | NCT00313859 | Colorectal Canc... Metastasis | simvastatin | 18 Years - | Samsung Medical Center | |
Lenalidomide and Cetuximab in Patients With Advanced Solid Tumors | NCT01166035 | Solid Tumors | Lenalidomide Cetuximab | 18 Years - 80 Years | Medical University Innsbruck | |
Evaluating Tools for Health Promotion and Disease Prevention | NCT00164658 | Coronary Heart ... Stroke Diabetes Breast Cancer Ovarian Cancer Colorectal Canc... | Familial risk a... | 35 Years - 65 Years | Centers for Disease Control and Prevention | |
Performance Evaluation of the NaviAid™ G-Eye System | NCT01552200 | Colorectal Canc... Polyp Adenoma | Group A-Standar... Group B-NaviAid... | 40 Years - | Smart Medical Systems Ltd. | |
Postoperative Folfox4 Only Versus Folfox4 Plus Transhepatic Arterial Chemotherapy (TAC) in the Treatment Unresectable Liver Metastasis of Colorectal Cancer | NCT00869271 | Unresectable Li... | tac + folfox4 Folfox4 | 18 Years - 75 Years | Fudan University | |
Perioperative Management of Colorectal Cancer Patients Infected With COVID-19: a Multicenter Prospective Cohort Study. | NCT05682898 | Colorectal Canc... Surgical Proced... | Timing of color... | - | Changhai Hospital | |
4-week Serial FIT Analysis in Patients With CRC | NCT04242901 | Colorectal Canc... | Faecal Immunoch... | 18 Years - | Nottingham University Hospitals NHS Trust | |
Encorafenib Plus Cetuximab in a Neoadjuvant Setting in Patients With BRAF Mutation Localised Colon or Upper Rectum Cancer | NCT05706779 | Colorectal Canc... BRAF V600E Muta... | Encorafenib Ora... | 18 Years - | Federation Francophone de Cancerologie Digestive | |
Pre- and Post-operative FOLFOX Based Therapy for Patients With Colorectal Cancer With Liver Involvement | NCT00537823 | Colorectal Canc... Metastases | Cetuximab Bevacizumab Leucovorin Oxaliplatin Fluorouracil | 18 Years - | Washington University School of Medicine |